These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 17608773)

  • 1. Synergistic action of the microRNA-17 polycistron and Myc in aggressive cancer development.
    Tagawa H; Karube K; Tsuzuki S; Ohshima K; Seto M
    Cancer Sci; 2007 Sep; 98(9):1482-90. PubMed ID: 17608773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma.
    Ota A; Tagawa H; Karnan S; Tsuzuki S; Karpas A; Kira S; Yoshida Y; Seto M
    Cancer Res; 2004 May; 64(9):3087-95. PubMed ID: 15126345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic dissection of the miR-17~92 cluster of microRNAs in Myc-induced B-cell lymphomas.
    Mu P; Han YC; Betel D; Yao E; Squatrito M; Ogrodowski P; de Stanchina E; D'Andrea A; Sander C; Ventura A
    Genes Dev; 2009 Dec; 23(24):2806-11. PubMed ID: 20008931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Burkitt lymphoma beyond MYC translocation: N-MYC and DNA methyltransferases dysregulation.
    De Falco G; Ambrosio MR; Fuligni F; Onnis A; Bellan C; Rocca BJ; Navari M; Etebari M; Mundo L; Gazaneo S; Facchetti F; Pileri SA; Leoncini L; Piccaluga PP
    BMC Cancer; 2015 Oct; 15():668. PubMed ID: 26453442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-17-92 cluster microRNAs confers tumorigenicity in multiple myeloma.
    Chen L; Li C; Zhang R; Gao X; Qu X; Zhao M; Qiao C; Xu J; Li J
    Cancer Lett; 2011 Oct; 309(1):62-70. PubMed ID: 21664042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MYC and aggressive B-cell lymphomas.
    Slack GW; Gascoyne RD
    Adv Anat Pathol; 2011 May; 18(3):219-28. PubMed ID: 21490439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A microRNA polycistron as a potential human oncogene.
    He L; Thomson JM; Hemann MT; Hernando-Monge E; Mu D; Goodson S; Powers S; Cordon-Cardo C; Lowe SW; Hannon GJ; Hammond SM
    Nature; 2005 Jun; 435(7043):828-33. PubMed ID: 15944707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR expression in MYC-negative DLBCL/BL with partial trisomy 11 is similar to classical Burkitt lymphoma and different from diffuse large B-cell lymphoma.
    Zajdel M; Rymkiewicz G; Chechlinska M; Blachnio K; Pienkowska-Grela B; Grygalewicz B; Goryca K; Cieslikowska M; Bystydzienski Z; Swoboda P; Walewski J; Siwicki JK
    Tumour Biol; 2015 Jul; 36(7):5377-88. PubMed ID: 25677902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homogeneous immunophenotype and paucity of secondary genomic aberrations are distinctive features of endemic but not of sporadic Burkitt's lymphoma and diffuse large B-cell lymphoma with MYC rearrangement.
    Barth TF; Müller S; Pawlita M; Siebert R; Rother JU; Mechtersheimer G; Kitinya J; Bentz M; Möller P
    J Pathol; 2004 Aug; 203(4):940-5. PubMed ID: 15258997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a real-time reverse transcription polymerase chain reaction assay for c-myc expression that allows the identification of a subset of c-myc+ diffuse large B-cell lymphoma.
    Sáez AI; Artiga MJ; Romero C; Rodríguez S; Cigudosa JC; Pérez-Rosado A; Fernández I; Sánchez-Beato M; Sánchez E; Mollejo M; Piris MA
    Lab Invest; 2003 Feb; 83(2):143-52. PubMed ID: 12594230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The miR-106b-25 polycistron, activated by genomic amplification, functions as an oncogene by suppressing p21 and Bim.
    Kan T; Sato F; Ito T; Matsumura N; David S; Cheng Y; Agarwal R; Paun BC; Jin Z; Olaru AV; Selaru FM; Hamilton JP; Yang J; Abraham JM; Mori Y; Meltzer SJ
    Gastroenterology; 2009 May; 136(5):1689-700. PubMed ID: 19422085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [DNA sequencing of miR-17-92 cluster at chromosome 13q31-q32 in mantel cell lymphoma cell lines].
    Xu W; Li JY; Shen QD; Li L; Yu H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Oct; 15(5):986-8. PubMed ID: 17956675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Molecular genetic features of sporadic Burkitt's lymphoma in children].
    Yang WP; Huang H; Gong LP; Wu Y; Xu HY; Zou Y; Lü BB; Zhong HS; Deng QQ; Xiao Q; Zeng ST; Zhu CD
    Zhonghua Bing Li Xue Za Zhi; 2010 Dec; 39(12):819-24. PubMed ID: 21215097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus (EBV) genomes and c-myc oncogene in oral Burkitt's lymphomas.
    Syrjänen S; Kallio P; Sainio P; Fuju C; Syrjänen K
    Scand J Dent Res; 1992 Jun; 100(3):176-80. PubMed ID: 1321486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic and clinical analysis of amplification of the 13q31 chromosomal region in alveolar rhabdomyosarcoma: a report from the Children's Oncology Group.
    Reichek JL; Duan F; Smith LM; Gustafson DM; O'Connor RS; Zhang C; Dunlevy MJ; Gastier-Foster JM; Barr FG
    Clin Cancer Res; 2011 Mar; 17(6):1463-73. PubMed ID: 21220470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation.
    Hayashita Y; Osada H; Tatematsu Y; Yamada H; Yanagisawa K; Tomida S; Yatabe Y; Kawahara K; Sekido Y; Takahashi T
    Cancer Res; 2005 Nov; 65(21):9628-32. PubMed ID: 16266980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic profiling of Richter's syndrome: recurrent lesions and differences with de novo diffuse large B-cell lymphomas.
    Scandurra M; Rossi D; Deambrogi C; Rancoita PM; Chigrinova E; Mian M; Cerri M; Rasi S; Sozzi E; Forconi F; Ponzoni M; Moreno SM; Piris MA; Inghirami G; Zucca E; Gattei V; Rinaldi A; Kwee I; Gaidano G; Bertoni F
    Hematol Oncol; 2010 Jun; 28(2):62-7. PubMed ID: 20014148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MYC status determination in aggressive B-cell lymphoma: the impact of FISH probe selection.
    Muñoz-Mármol AM; Sanz C; Tapia G; Marginet R; Ariza A; Mate JL
    Histopathology; 2013 Sep; 63(3):418-24. PubMed ID: 23795946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The miR-17-92 microRNA polycistron regulates MLL leukemia stem cell potential by modulating p21 expression.
    Wong P; Iwasaki M; Somervaille TC; Ficara F; Carico C; Arnold C; Chen CZ; Cleary ML
    Cancer Res; 2010 May; 70(9):3833-42. PubMed ID: 20406979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simple karyotype and bcl-6 expression predict a diagnosis of Burkitt lymphoma and better survival in IG-MYC rearranged high-grade B-cell lymphomas.
    Seegmiller AC; Garcia R; Huang R; Maleki A; Karandikar NJ; Chen W
    Mod Pathol; 2010 Jul; 23(7):909-20. PubMed ID: 20348878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.